Target intelligence / Profile preview

Ribosomal protein S29 pseudogene 19 (RPS29P19)

Target
RPS29P19
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein S29 pseudogene 19 (RPS29P19) is classified as a processed pseudogene in the human genome. It originates from the RPS29 gene, which encodes a structural component of the 40S subunit of ribosomes involved in protein synthesis. As a pseudogene, RPS29P19 does not produce a functional protein product and is not known to play a direct biological role or be involved in therapeutic targeting. The presence of such pseudogenes in the genome is a reflection of evolutionary duplications and retrotranspositions of functional ribosomal protein genes, but these copies typically lack the regulatory elements or intact coding sequences necessary for expression. There is no evidence suggesting pseudogenes like RPS29P19 are implicated in human disease, serve as biomarkers, have drug interactions, or present any specific safety concerns. RPS29P19 is not a therapeutic target and is not a misnamed receptor or enzyme; it is a non-functional genomic sequence derived from the RPS29 functional gene. If you intended to refer to the functional ribosomal protein, use "Ribosomal protein S29" or "RPS29".

Other names
RPS29_4_1178RPS29P19

Beyond the preview

Go deeper on Ribosomal protein S29 pseudogene 19 (RPS29P19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S29 pseudogene 19 (RPS29P19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call